The seasonal influenza [flu] vaccine is available for priority groups through their doctor or the Flu Express,” the ...
In addition to trivalent inactivated influenza vaccines or trivalent recombinant influenza vaccine, the ACIP now recommends high-dose inactivated influenza vaccine (Fluzone High-Dose) or ...
The pandemic influenza vaccines business is even more unpredictable and depends almost exclusively on government stockpiling and supply contracts. A re-emerging focus for vaccine players ...
The combination candidate consists of Pfizer’s mRNA-based influenza vaccine candidate with the companies’ licensed COVID-19 vaccine. The Phase 3 trial measured two primary immunogenicity ...
(RTTNews) - GSK plc (GSK), Thursday announced positive data from a phase II trial for its mRNA seasonal influenza vaccine programme. The study evaluated the reactogenicity, safety, and ...
GSK plc announced positive headline results of a phase II trial (NCT06431607) for its mRNA seasonal influenza vaccine programme. The trial studied a range of mRNA formulations in older and younger ...
It is not inevitable that H5N1 will develop into a pandemic -- if we act now. Unfortunately, instead of urgent action, we ...
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program 12.09.2024 / 12:57 CET/CEST The issuer is solely responsible for the content of this announcement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback